India has the capability to produce over 500 crore doses of the coronavirus vaccine by the end of the next year, Prime Minister Narendra M...
India has the capability to produce over 500 crore doses of the coronavirus vaccine by the end of the next year, Prime Minister Narendra Modi said at a summit of the G20 countries in Rome on Saturday.
At the first session of the summit, speaking on global economy and global health, the prime minister also asserted that it was essential that the World Health Organization approves India’s coronavirus vaccine, Covaxin, “at the earliest”.
The Bharat Biotech vaccine is yet to receive approval for emergency use from the World Health Organization even as India had applied for the clearance in April. Emergency use listing is a procedure by the global health body to approve vaccines and other products for use during public health emergencies.
On Thursday, an official of the global health body had said that the vaccine was at its “last stage of the assessment”. The official also said that she hoped for a final recommendation this week.
In his address on Saturday, Modi called upon the G20 nations to ensure mutual recognition of vaccine certificates. He said scaling up international travel was crucial for a global economic recovery.
Modi urged member nations of the G20 to work towards the vision of “One Earth, One Health”.
“I am talking about collaboration in research and development, collaboration across...
